Delivery Order SPE2DB25D3402-SPE2DB25FUFWT

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.47 Firm Fixed Price Delivery Order contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Tobradex eye ointment to support federal government healthcare programs. The $1,436.25 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense that provides medical supplies to military treatment facilities and other federal healthcare providers. The contract has an ultimate completion date...
This federal contract award, valued at $1,082.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order. This award does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Tobradex Eye Ointment 3.5 GM. The $3,244.52 firm-fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical ophthalmic medication supplies to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,700.32 Firm Fixed Price Delivery Order is for the supply of Tobradex Eye Ointment, a prescription ophthalmic medication. The contract has a completion date of July 3, 2024 and does not have any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,068.18 firm-fixed-price contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product, with a performance period through August 7, 2024. This contract is not set-aside for any small business program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $1,092.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,330,497 units of TOBRADEX Eye Ointment 3.5GM. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical commodities to support military...
This federal contract award, valued at $1,323.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. This is a delivery order contract with a firm-fixed price pricing type, with an ultimate completion date of November 6, 2023. The contract does not have a set-aside designation, indicating open...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX Eye Ointment 3.5GM. The $3,547.88 firm fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office Division, will deliver these medical supplies to support federal healthcare providers and programs. This delivery order is part of a larger...
This federal contract award is a Delivery Order (DO) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The DO, valued at $1,158.24, is for the supply of Tobradex Eye Ointment, a medical product used for the treatment of various eye conditions. This award is not associated with a set-aside program. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB25D3402
    Indefinite Delivery Contract
  • SPE2DB25D3402-SPE2DB25FUFWT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tobradex Eye Ointment 3.5GM. The contract, valued at $1,572.17, is a Firm Fixed Price Delivery Order with a completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:36 AM